HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

Abroad (travel likely)RecruitingPHASE1

Conditions

Myeloid Malignancy · Acute Myeloid Leukemia · Myelodysplastic Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Study coordinator (Mark Juckett, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of GLB-001 in Patients With Myeloid Malignancies

Polycythemia Vera · Essential Thrombocythemia · Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Hefei, China · Beijing, China

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE2

St Louis, United States · Pittsburgh, United States